Revelation Biosciences, Inc.

REVB·NasdaqCM·Healthcare
Compare
4.1177−0.3123 (−7.05%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.4300
Open4.4300
Day range3.85004.4300
52-week range3.080040.6000
Off day high−7.05%
Off 52-week high−89.86%
Volume11.23K
Avg. volume (3M)11.24K
Market cap2.34M
EPS (TTM)32.20
Forward P/E-0.20
P/E ratio (TTM)0.13
Dividend yield—
Beta (5Y)-0.06
Shares outstanding569.06K
Short interest0.17% of float
Earnings dateNov 5, 2026 (est.)
Analyst target124.2500
Profit margin0.00%

Against its peers

Compare in full ›
REVB CVKD XRTX KAPA ARTL PCSA
Market cap 2.34M 3.78M 1.80M 1.66M 1.24M 5.41M
P/E (TTM) 0.1 — — — — —
Forward P/E -0.2 -0.3 1.2 -0.1 -2.6 -0.5
Price/book 0.2 0.8 0.3 0.4 0.2 -17.0
Dividend yield — — — — — —
1-year change −85.35% −91.14% −67.48% −92.33% −95.46% −75.51%
Today −7.05% −6.19% −1.00% −3.03% −5.42% −0.26%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All REVB news ›

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance